Want to see HK:2157 full AI Analyst Report?
Lepu Biopharma Co. Ltd. Class H (2157) Financial Statements
Lepu Biopharma Co. Ltd. Class H Financial Overview
Lepu Biopharma Co. Ltd. Class H's market cap is currently $5.69B. The company's EPS TTM is $0.14; its P/E ratio is 19.79; Lepu Biopharma Co. Ltd. Class H is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 910.67M | $ 367.79M | $ 225.35M | $ 15.57M | $ 0.00 |
| Gross Profit | $ 732.10M | $ 292.97M | $ 197.07M | $ 13.57M | $ -114.79M |
| Operating Income | $ 87.43M | $ -390.76M | $ 4.80M | $ -704.48M | $ -1.01B |
| EBITDA | $ 178.73M | $ -295.67M | $ 86.95M | $ -596.53M | $ -848.43M |
| Net Income | $ 254.60M | $ -411.38M | $ -22.10M | $ -689.05M | $ -1.01B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 959.17M | $ 464.91M | $ 489.64M | $ 678.20M | $ 205.17M |
| Total Assets | $ 3.10B | $ 2.28B | $ 2.38B | $ 2.53B | $ 2.08B |
| Total Debt | $ 1.06B | $ 850.16M | $ 746.82M | $ 690.30M | $ 335.26M |
| Net Debt | $ 205.13M | $ 448.88M | $ 320.81M | $ 20.91M | $ 180.09M |
| Total Liabilities | $ 1.72B | $ 1.60B | $ 1.50B | $ 1.63B | $ 1.23B |
| Stockholders' Equity | $ 1.39B | $ 702.83M | $ 896.90M | $ 900.76M | $ 836.71M |
| Cash Flow | |||||
| Free Cash Flow | $ -82.80M | $ -258.14M | $ -292.04M | $ -591.38M | $ -835.12M |
| Operating Cash Flow | $ -38.56M | $ -196.39M | $ -250.84M | $ -480.93M | $ -621.74M |
| Investing Cash Flow | $ -149.19M | $ -61.75M | $ 18.26M | $ -74.66M | $ -3.89M |
| Financing Cash Flow | $ 620.94M | $ 232.08M | $ -11.01M | $ 1.03B | $ 380.31M |
Currency in CNY